个人中心 - 老虎社区

Joyce124

IP属地：广东

帖子 · 114帖子 · 114
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- Joyce124Joyce124
  ·05-22
  $植华集团(01842)$ 大神带回本呗！输少我都当年了！拿了几年了[流泪] [流泪] [流泪] [流泪]
  623 评论
  1
  分享
  举报
- Joyce124Joyce124
  ·05-09
  $开拓药业-B(09939)$ 好过份哦
  576 评论
  1
  分享
  举报
- Joyce124Joyce124
  ·04-10
  $开拓药业-B(09939)$ 好贱！
  405 评论
  点赞
  分享
  举报
- Joyce124Joyce124
  ·04-02
  $植华集团(01842)$ 回个本就这么难吗？
  456 评论
  点赞
  分享
  举报
- Joyce124Joyce124
  ·02-16
  最高峰70多块钱的！现在0.96[捂脸] [捂脸] [捂脸] [捂脸]
  困境中的转机——嘉和生物与亿腾医药合并
  2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。此次合并亿腾医药，将使得嘉和生物能够借助亿腾医药强大的商业化能力，将手中的创新药物更快地推向市场，实现商业化收益。当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方：企业应该如何根据自身优势和市场环境，制定出合适的发展战略？
  困境中的转机——嘉和生物与亿腾医药合并
  954 评论
  点赞
  分享
  举报
- Joyce124Joyce124
  ·01-23
  $植华集团(01842)$ 一个股票⼀直涨是想让你买，股票⼀直跌是想要你卖！
  825 评论
  点赞
  分享
  举报
- Joyce124Joyce124
  ·2024-09-02
  $植华集团(01842)$ 哎⋯⋯什么时候才回本？
  1,703 评论
  点赞
  分享
  举报
- Joyce124Joyce124
  ·2024-06-25
  $开拓药业-B(09939)$ 股票就是将你的钱弄到我的口袋！
  2,230 评论
  1
  分享
  举报
- Joyce124Joyce124
  ·2024-06-05
  $开拓药业-B(09939)$ 太恶心了
  1,613 评论
  点赞
  分享
  举报
- Joyce124Joyce124
  ·2024-06-03
  $开拓药业-B(09939)$ 好贱的股票！
  1,410 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3584064374196548","uuid":"3584064374196548","gmtCreate":1620971360279,"gmtModify":1620971360279,"name":"Joyce124","pinyin":"joyce124","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":7,"tweetSize":114,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.81%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.24%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":6,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":437631030759992,"gmtCreate":1747874172665,"gmtModify":1747878113662,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 大神带回本呗！输少我都当年了！拿了几年了[流泪]&nbsp; [流泪]&nbsp; [流泪]&nbsp; [流泪]&nbsp;&nbsp;","listText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 大神带回本呗！输少我都当年了！拿了几年了[流泪]&nbsp; [流泪]&nbsp; [流泪]&nbsp; [流泪]&nbsp;&nbsp;","text":"$植华集团(01842)$ 大神带回本呗！输少我都当年了！拿了几年了[流泪] [流泪] [流泪] [流泪]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/437631030759992","isVote":1,"tweetType":1,"viewCount":623,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":433056947356104,"gmtCreate":1746760220874,"gmtModify":1746760222233,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好过份哦","listText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好过份哦","text":"$开拓药业-B(09939)$ 好过份哦","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/433056947356104","isVote":1,"tweetType":1,"viewCount":576,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":423069229441320,"gmtCreate":1744256665732,"gmtModify":1744258381447,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好贱！","listText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好贱！","text":"$开拓药业-B(09939)$ 好贱！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/423069229441320","isVote":1,"tweetType":1,"viewCount":405,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":419969055334776,"gmtCreate":1743562729969,"gmtModify":1743563375655,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 回个本就这么难吗？","listText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 回个本就这么难吗？","text":"$植华集团(01842)$ 回个本就这么难吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/419969055334776","isVote":1,"tweetType":1,"viewCount":456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":404115656814792,"gmtCreate":1739685752994,"gmtModify":1739685754889,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"最高峰70多块钱的！现在0.96[捂脸]&nbsp; [捂脸]&nbsp; [捂脸]&nbsp; [捂脸]&nbsp;&nbsp;","listText":"最高峰70多块钱的！现在0.96[捂脸]&nbsp; [捂脸]&nbsp; [捂脸]&nbsp; [捂脸]&nbsp;&nbsp;","text":"最高峰70多块钱的！现在0.96[捂脸] [捂脸] [捂脸] [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/404115656814792","repostId":"2511638680","repostType":2,"repost":{"id":"2511638680","kind":"news","pubTimestamp":1739505882,"share":"https://ttm.financial/m/news/2511638680?lang=&edition=full","pubTime":"2025-02-14 12:04","market":"hk","language":"zh","title":"困境中的转机——嘉和生物与亿腾医药合并","url":"https://stock-news.laohu8.com/highlight/detail?id=2511638680","media":"新浪财经","summary":"2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。此次合并亿腾医药，将使得嘉和生物能够借助亿腾医药强大的商业化能力，将手中的创新药物更快地推向市场，实现商业化收益。当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方：企业应该如何根据自身优势和市场环境，制定出合适的发展战略？","content":"<html><body><article><p>在 生物医药 领域融资困境持续存在的背景下，本土biotech企业迎来了一场引人注目的大型并购案。2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。</p><p>此次并购事件堪称业界瞩目的现象级交易。嘉和生物的研发能力和具有潜力的产品管线一直备受瞩目。而亿腾医药也以其出色的商业化能力和稳定的现金流在业界占有一席之地。此次并购将使双方 优势资源 进行深度融合与高效整合，为中国 创新药 企开辟了一条全新且具有潜力的发展路径。</p><p>亿腾医药的上市之路遭遇挑战，面对当前IPO市场表现持续低迷的困境，亿腾医药选择通过嘉和生物进行“借壳上市”，无疑是一个深思熟虑且明智的战略部署。此举旨在加速企业进军 资本市场 的步伐，同时为公司开辟更为广阔的融资渠道，并为其后续发展创造更大的空间和机遇。</p><p>嘉和生物虽然曾在2020年成功实现IPO，但近年来却面临着新品研发慢人一步、PD-1上市被否、裁员等困境。然而，其手中的众多潜力靶点和创新管线仍具有巨大的价值。此次合并亿腾医药，将使得嘉和生物能够借助亿腾医药强大的商业化能力，将手中的创新药物更快地推向市场，实现商业化收益。</p><p>合并后的新公司亿腾嘉和未来的发展模式将更加注重海内外资源的整合与利用。在拓展中国商业化发展的同时，通过包括NewCo模式等的出海方式布局海外市场，寻求新增量空间。这种发展模式不仅有助于提升企业的国际竞争力，还将为中国创新药企的全球化发展探索出一条新的路径。</p><p>此次并购事件将是港股18A公司交易活动启动的预示，同时也为当前仍在积极寻求发展路径的部分药企开辟了新的思路与方向。在生物医药领域，创新药物研发具有独特的魅力，时常在业界预期之外的地方绽放出新的希望与活力。正是这种不可预测性，促使着众多企业与投资者络绎不绝地投身其中，不断追寻着前行的动力与机遇。</p><p>当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方：企业应该如何根据自身优势和市场环境，制定出合适的发展战略？如何实现企业的可 持续发展 ？这些问题都需要企业不断探索。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>困境中的转机——嘉和生物与亿腾医药合并</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n困境中的转机——嘉和生物与亿腾医药合并\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-14 12:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214122036abce64bf&s=b><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>在 生物医药 领域融资困境持续存在的背景下，本土biotech企业迎来了一场引人注目的大型并购案。2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。此次并购事件堪称业界瞩目的现象级交易。嘉和生物的研发能力和具有潜力的产品管线一直备受瞩目。而亿腾医药也以其出色的商业化能力和稳定的现金流在业界占有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214122036abce64bf&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214122036abce64bf&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2511638680","content_text":"在 生物医药 领域融资困境持续存在的背景下，本土biotech企业迎来了一场引人注目的大型并购案。2024年10月7日，港股18A公司嘉和生物发布公告，宣布与亿腾医药订立合并协议，亿腾医药将反向并购嘉和生物，合并后的新公司名称预计将改为“亿腾嘉和”。此次并购事件堪称业界瞩目的现象级交易。嘉和生物的研发能力和具有潜力的产品管线一直备受瞩目。而亿腾医药也以其出色的商业化能力和稳定的现金流在业界占有一席之地。此次并购将使双方 优势资源 进行深度融合与高效整合，为中国 创新药 企开辟了一条全新且具有潜力的发展路径。亿腾医药的上市之路遭遇挑战，面对当前IPO市场表现持续低迷的困境，亿腾医药选择通过嘉和生物进行“借壳上市”，无疑是一个深思熟虑且明智的战略部署。此举旨在加速企业进军 资本市场 的步伐，同时为公司开辟更为广阔的融资渠道，并为其后续发展创造更大的空间和机遇。嘉和生物虽然曾在2020年成功实现IPO，但近年来却面临着新品研发慢人一步、PD-1上市被否、裁员等困境。然而，其手中的众多潜力靶点和创新管线仍具有巨大的价值。此次合并亿腾医药，将使得嘉和生物能够借助亿腾医药强大的商业化能力，将手中的创新药物更快地推向市场，实现商业化收益。合并后的新公司亿腾嘉和未来的发展模式将更加注重海内外资源的整合与利用。在拓展中国商业化发展的同时，通过包括NewCo模式等的出海方式布局海外市场，寻求新增量空间。这种发展模式不仅有助于提升企业的国际竞争力，还将为中国创新药企的全球化发展探索出一条新的路径。此次并购事件将是港股18A公司交易活动启动的预示，同时也为当前仍在积极寻求发展路径的部分药企开辟了新的思路与方向。在生物医药领域，创新药物研发具有独特的魅力，时常在业界预期之外的地方绽放出新的希望与活力。正是这种不可预测性，促使着众多企业与投资者络绎不绝地投身其中，不断追寻着前行的动力与机遇。当然嘉和生物与亿腾医药的合并事件也为我们留下了许多值得思考的地方：企业应该如何根据自身优势和市场环境，制定出合适的发展战略？如何实现企业的可 持续发展 ？这些问题都需要企业不断探索。","news_type":1,"symbols_score_info":{"06998":1,"09939":1}},"isVote":1,"tweetType":1,"viewCount":954,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":395561982677680,"gmtCreate":1737600699445,"gmtModify":1737602077180,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 一个股票⼀直涨是想让你买，股票⼀直跌是想要你卖！","listText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 一个股票⼀直涨是想让你买，股票⼀直跌是想要你卖！","text":"$植华集团(01842)$ 一个股票⼀直涨是想让你买，股票⼀直跌是想要你卖！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/395561982677680","isVote":1,"tweetType":1,"viewCount":825,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":345061094244536,"gmtCreate":1725270287140,"gmtModify":1725270387747,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 哎⋯⋯什么时候才回本？","listText":"<a href=\"https://laohu8.com/S/01842\">$植华集团(01842)$</a> 哎⋯⋯什么时候才回本？","text":"$植华集团(01842)$ 哎⋯⋯什么时候才回本？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/345061094244536","isVote":1,"tweetType":1,"viewCount":1703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":320534808531088,"gmtCreate":1719288448579,"gmtModify":1719288450127,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 股票就是将你的钱弄到我的口袋！","listText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 股票就是将你的钱弄到我的口袋！","text":"$开拓药业-B(09939)$ 股票就是将你的钱弄到我的口袋！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/320534808531088","isVote":1,"tweetType":1,"viewCount":2230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":313552921391400,"gmtCreate":1717589432412,"gmtModify":1717592982430,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 太恶心了","listText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 太恶心了","text":"$开拓药业-B(09939)$ 太恶心了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/313552921391400","isVote":1,"tweetType":1,"viewCount":1613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":312852022837304,"gmtCreate":1717402170856,"gmtModify":1717404931395,"author":{"id":"3584064374196548","authorId":"3584064374196548","name":"Joyce124","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3584064374196548","authorIdStr":"3584064374196548"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好贱的股票！","listText":"<a href=\"https://laohu8.com/S/09939\">$开拓药业-B(09939)$</a> 好贱的股票！","text":"$开拓药业-B(09939)$ 好贱的股票！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/312852022837304","isVote":1,"tweetType":1,"viewCount":1410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}